Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials

Objectives: This study systematically reviewed the published literature from clinical trials on the efficacy and immunogenicity of single-dose HPV vaccination compared to multidose schedules or no HPV vaccination. Methods: Four databases were searched for relevant articles published from Jan-1999 to...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Hilary S. Whitworth, Sandra Mounier-Jack, Edward M. Choi, Katherine E. Gallagher, Natasha Howard, Helen Kelly, Gladys Mbwanji, Aimée R Kreimer, Partha Basu, Ruanne Barnabas, Mélanie Drolet, Marc Brisson, Deborah Watson-Jones
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Elsevier 2024-08-01
Sraith:	Vaccine: X
Ábhair:	Human papillomavirus Vaccine Dosage Efficacy Immunogenicity
Rochtain ar líne:	http://www.sciencedirect.com/science/article/pii/S2590136224000597

Míreanna comhchosúla

Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
de réir: Mingzhu Li, et al.
Foilsithe / Cruthaithe: (2023-03-01)

The effect of perceived psychological stress on the immunogenicity of the quadrivalent human papillomavirus vaccine in males
de réir: Rebecca F. Wu, et al.
Foilsithe / Cruthaithe: (2017-03-01)

Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals
de réir: Xiao-Juan Yu, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
de réir: Suzanne M. Garland, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial
de réir: Vu Dinh Thiem, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies
de réir: Anna R. Giuliano, et al.
Foilsithe / Cruthaithe: (2025-12-01)

Human papillomavirus vaccine: An update on recent developments and review of real world data on efficacy
de réir: Shalini Rajaram, et al.
Foilsithe / Cruthaithe: (2023-01-01)

A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine
de réir: Dan Xu, et al.
Foilsithe / Cruthaithe: (2024-11-01)

The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20–45 years of age
de réir: Tianmeng Wen, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Modelling multi-site transmission of the human papillomavirus and its impact on vaccination effectiveness
de réir: P. Lemieux-Mellouki, et al.
Foilsithe / Cruthaithe: (2017-12-01)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
de réir: Paulina N. Naupu, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Immunogenicity and safety of the fourth dose of quadrivalent human papillomavirus (HPV) vaccine in immunosuppressed women who did not seroconvert after three doses
de réir: Lívia Zignago Moreira dos Santos, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up
de réir: Sven-Eric Olsson, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior
de réir: Iacopo Baussano, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types
de réir: Katrina M. Nolan, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Application of reverse cumulative distribution curve and scaled logit model in determining optimal immunogenic dose and prediction of protection of EV71 vaccines
de réir: Lairun Jin, et al.
Foilsithe / Cruthaithe: (2025-12-01)

Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial
de réir: Zhao-Jun Mo, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years
de réir: Ivette Maldonado, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Sleep and vaccine administration time as factors influencing vaccine immunogenicity
de réir: Eun Seok Kim, et al.
Foilsithe / Cruthaithe: (2022-03-01)

In-silico Analysis of Human Papillomavirus – 45 E6, E7 & L1 Proteins as Potential Immunogens
de réir: Shruthi Padavu, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Quadrivalent HPV (4vHPV) vaccine immunogenicity and safety in women using immunosuppressive drugs due to solid organ transplant
de réir: Karina Takesaki Miyaji, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Optimal human papillomavirus vaccination strategies in the context of vaccine supply constraints in 100 countriesResearch in context
de réir: Kiesha Prem, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Discrepancies in the evaluation of the safety of the human papillomavirus vaccine
de réir: Jorge L Cervantes, et al.
Foilsithe / Cruthaithe: (2018-05-01)

Comparison of immunogenicity between hepatitis B vaccines with different dosages and schedules among healthy young adults in China: A 2-year follow-up study
de réir: Zhen-Zi Wang, et al.
Foilsithe / Cruthaithe: (2018-06-01)

Factors influencing the immunogenicity of influenza vaccines
de réir: Simin Wen, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial
de réir: Ying-Ying Su, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Human Papillomavirus Vaccine: A New Opportunity for The Treatment of Human Papillomavirus Infections
de réir: Sneha Ambwani, et al.
Foilsithe / Cruthaithe: (2014-06-01)

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals
de réir: Juan Li, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
de réir: Eva Hong, et al.
Foilsithe / Cruthaithe: (2017-03-01)

Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials
de réir: Chantal Sauvageau, et al.
Foilsithe / Cruthaithe: (2020-03-01)

Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
de réir: Jiawei Xu, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination
de réir: Steffi Silling, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Influences of obesity on the immunogenicity of Hepatitis B vaccine
de réir: Fang Liu, et al.
Foilsithe / Cruthaithe: (2017-05-01)

Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis
de réir: Sara Carazo, et al.
Foilsithe / Cruthaithe: (2020-03-01)

Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review
de réir: Mallory K. Ellingson, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection
de réir: Maria Zurek Munk-Madsen, et al.
Foilsithe / Cruthaithe: (2018-04-01)

Micronutrients to Support Vaccine Immunogenicity and Efficacy
de réir: Philip C. Calder, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study
de réir: Ingrid Herta Rotstein Grein, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Immunogenicity of Alternative Dosing Schedules for HPV Vaccines among Adolescent Girls and Young Women: A Systematic Review and Meta-Analysis
de réir: Andrew M. Secor, et al.
Foilsithe / Cruthaithe: (2020-10-01)

Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
de réir: Rodrigo Luiz Carregaro, et al.
Foilsithe / Cruthaithe: (2023-08-01)